Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Integrin β1 is crucial for liver structure and function, preventing fibrosis.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

KAP genes are crucial for hair development and show both shared and unique traits in humans, chimpanzees, and baboons.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

mIGF-1 in skin cells speeds up wound healing and hair growth in mice without harmful effects.

Icariin helps mouse hair grow by boosting a growth factor in skin cells.

JAK inhibitors show promise in treating difficult skin diseases.

HB24 helps convert IBA to IAA, promoting root hair growth.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Ritlecitinib was generally well tolerated in children with alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.